LT3498859T - Sarkozino nustatymas naudojant sarkozino oksidazę ir krienų peroksidazę, per chitozaną surištus fe2o3/au nanodalelėmis - Google Patents

Sarkozino nustatymas naudojant sarkozino oksidazę ir krienų peroksidazę, per chitozaną surištus fe2o3/au nanodalelėmis

Info

Publication number
LT3498859T
LT3498859T LTEP18211201.1T LT18211201T LT3498859T LT 3498859 T LT3498859 T LT 3498859T LT 18211201 T LT18211201 T LT 18211201T LT 3498859 T LT3498859 T LT 3498859T
Authority
LT
Lithuania
Prior art keywords
sarcosine
fe2o3
determination
horseradish peroxidase
nanoparticles via
Prior art date
Application number
LTEP18211201.1T
Other languages
English (en)
Inventor
Dagmar Uhlirova
Michaela Docekalova
Martina Stankova
Josef Ruzicka
René Kizek
Original Assignee
Prevention Medicals s.r.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevention Medicals s.r.o. filed Critical Prevention Medicals s.r.o.
Publication of LT3498859T publication Critical patent/LT3498859T/lt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G7/00—Compounds of gold
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/906—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
    • G01N2333/9065—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5)
    • G01N2333/90672—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3) in general
    • G01N2333/90677—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on CH-NH groups of donors (1.5) with oxygen as acceptor (1.5.3) in general with a definite EC number (1.5.3.-)
    • G01N2333/90683—Sarcosine oxidase (1.5.3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/24—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
    • G01N2400/28—Chitin, chitosan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Plasma & Fusion (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Manufacturing & Machinery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
LTEP18211201.1T 2017-12-18 2018-12-10 Sarkozino nustatymas naudojant sarkozino oksidazę ir krienų peroksidazę, per chitozaną surištus fe2o3/au nanodalelėmis LT3498859T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ2017-812A CZ307785B6 (cs) 2017-12-18 2017-12-18 Nanočástice Fe2O3/Au s navázanými enzymy sarkosin oxidázy a křenové peroxidázy pomocí chitosanu a jejich použití pro kvalitativní a kvantitativní stanovení sarkosinu v biologickém nebo environmentálním vzorku

Publications (1)

Publication Number Publication Date
LT3498859T true LT3498859T (lt) 2020-04-27

Family

ID=65033293

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP18211201.1T LT3498859T (lt) 2017-12-18 2018-12-10 Sarkozino nustatymas naudojant sarkozino oksidazę ir krienų peroksidazę, per chitozaną surištus fe2o3/au nanodalelėmis

Country Status (12)

Country Link
EP (1) EP3498859B1 (lt)
CY (1) CY1122955T1 (lt)
CZ (1) CZ307785B6 (lt)
DK (1) DK3498859T3 (lt)
ES (1) ES2781322T3 (lt)
HR (1) HRP20200421T1 (lt)
HU (1) HUE049042T2 (lt)
LT (1) LT3498859T (lt)
PL (1) PL3498859T3 (lt)
PT (1) PT3498859T (lt)
RS (1) RS60195B1 (lt)
SI (1) SI3498859T1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113000053B (zh) * 2021-03-02 2022-09-09 广东工业大学 一种Au-Au/IrO2@Cu(PABA)级联反应器
CN113804633B (zh) * 2021-09-15 2023-07-11 中国石油大学(华东) 基于Au-Fe3O4纳米材料的沙门氏菌识别免疫探针的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105695442B (zh) * 2015-12-02 2019-06-21 浙江工商大学 用于酶固定化的改性磁性壳聚糖微球、其制备方法及应用
CZ30896U1 (cs) * 2017-05-16 2017-08-08 Prevention Medicals s.r.o. Reakční směs pro kvantitativní stanovení sarkosinu ve vzorku lidské moči, séra nebo plazmy
CZ30895U1 (cs) * 2017-05-16 2017-08-08 Prevention Medicals s.r.o. Reakční směs pro kvantitativní stanovení kreatininu ve vzorku lidské moči, séra nebo plazmy
CZ30831U1 (cs) * 2017-05-16 2017-07-11 Prevention Medicals s.r.o. Diagnostický proužek pro stanovení množství sarkosinu, kreatininu a peroxidu vodíku v biologickém nebo environmentálním vzorku
CZ30902U1 (cs) * 2017-06-19 2017-08-08 Prevention Medicals s.r.o. Diagnostický proužek pro kvantitativní stanovení sarkosinu v biologickém vzorku pomocí protilátek proti sarkosinu a nanočástic zlata s peroxidázovou aktivitou nebo kvantových teček

Also Published As

Publication number Publication date
EP3498859A1 (en) 2019-06-19
SI3498859T1 (sl) 2020-07-31
HUE049042T2 (hu) 2020-09-28
DK3498859T3 (da) 2020-03-30
HRP20200421T1 (hr) 2020-06-12
ES2781322T3 (es) 2020-09-01
PL3498859T3 (pl) 2020-06-29
RS60195B1 (sr) 2020-06-30
EP3498859B1 (en) 2020-01-08
CY1122955T1 (el) 2021-10-29
PT3498859T (pt) 2020-04-24
CZ2017812A3 (cs) 2019-05-02
CZ307785B6 (cs) 2019-05-02

Similar Documents

Publication Publication Date Title
EP3558369A4 (en) ANTIBODIES SPECIFICALLY BINDING TO HUMAN IL-15 AND THEIR USES
IL256630A (en) Combined separator and coagulator
EP3484469A4 (en) COMPOSITIONS AND METHODS FOR THE POTENTIALIZATION OF ANTIMICROBIAL AGENTS
EP3294289A4 (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
MX2017002085A (es) Tratamientos con nanopartículas núcleo-corteza de proteína/oligonucleótido.
ZA201906813B (en) Antibody binding specifically to muc1 and use thereof
EP3187189A4 (en) Composition and medicinal product for reducing body weight and body fat, and use of said product
EP3674401A4 (en) MANGANESE PEROXIDASE, CORRESPONDING GENE AND ITS USE IN THE DETOXICATION OF A MYCOTOXIN
EP3172224A4 (en) Factor h binding protein variants and methods of use thereof
PT3498859T (pt) Determinação de sarcosina oxidase e peroxidase de rábano silvestre ligadas a nanopartículas de fe2o3/au através de quitosano
GB202003778D0 (en) Use of lactoferrin
EP3518898A4 (en) PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
IL271073A (en) b4galt1 variants and their uses
EP3249544A4 (en) Personal working system capable of being dynamically combined and adjusted
EP3866768A4 (en) USING REBOXETINE TO TREAT NARCOLEPSY
EP3295175A4 (en) Targeted protein contrast agents, methods of making, and uses thereof
EP3702465A4 (en) CONSTRUCTION INTENDED FOR THE EXPRESSION OF A G-PROTEIN-COUPLED RECEPTOR OR A SUB-UNIT THEREOF, AND APPLICATION OF THIS CONSTRUCTION
EP3677041A4 (en) CUSTOMER-SIDE MESH OF A SECONDARY CONTENT
EP3638748A4 (en) ENHANCED DESTRUCTION OF SULPHATE-REDUCING BACTERIA BY STAGED SEQUENTIAL ADDING OF OXYANION AND BIOCIDE
EP3595718A4 (en) ANTIBODIES DIRECTED AGAINST ERYTHROFERRONE AND THEIR USES
EP3116890A4 (en) Asymmetric interfering rna compositions that silence k-ras and methods of uses thereof
MY179637A (en) Adenoviral vector encoding human atonal homolog-1 (hath1)
PT3684973T (pt) Composição polimérica de melhoramento da resistência do papel e sistema aditivo, sua utilização e fabrico de produtos de papel
EP3618643A4 (en) ANIMAL FEED COMPOSITIONS AND METHOD OF USE
GB201705071D0 (en) Sweat-inhibiting and/or deoderizing cosmetic agents with low emulsifier content